Early treatment of hemophilia with minimal doses of factor VIII or factor IX.
D004305:Dose-Response Relationship, Drug; D005164:Factor IX / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D013997:Time Factors
D005169:Factor VIII; D005164:Factor IX